Pathogenica, Life Technologies Partner on Sequencing-based HAI Dx | GenomeWeb

NEW YORK (GenomeWeb News) – Pathogenica today announced that it has signed a co-marketing pact with Life Technologies for sequencing-based diagnostic tests targeting hospital-acquired infections.

The exclusive deal covers Europe, the Middle East, and Africa and will combine Pathogenica's DxSeq technology with Life Tech's Ion Torrent PGM platform. The kits will be distributed for research use, the firms said, and are not for use in diagnosing hospital patients.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.